W. Andrew Yeudall

Dissecting the Akt/Mammalian Target of Rapamycin Signaling Network: Emerging Results from the Head and Neck Cancer Tissue Array Initiative

Alfredo Molinolo, Stephen M. Hewitt, Panomwat Amornphimoltham et al. · Clinical Cancer Research · 2007 · 249 citations

Medicine, Molecular Biology, Oncology +17

p53 gene mutations in pituitary adenomas: rare events

Andrew Levy, Leonard Hall, W. Andrew Yeudall et al. · Clinical Endocrinology · 1994 · 152 citations

Medicine, Endocrinology, Pathology +17

Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration

W. Andrew Yeudall, Catherine A. Vaughan, Hiroshi Miyazaki et al. · Carcinogenesis · 2011 · 120 citations

Medicine, Molecular Biology, Oncology +17

Down-regulation of CXCL5 Inhibits Squamous Carcinogenesis

Hiroshi Miyazaki, Vyomesh Patel, Hui‐Xin Wang et al. · Cancer Research · 2006 · 108 citations

Medicine, Cell Biology, Oncology +17

Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility

Rachel J. Paccione, Hiroshi Miyazaki, Vyomesh Patel et al. · Molecular Cancer Therapeutics · 2008 · 98 citations · Full text

Life Sciences, Cell Biology, Oncology +17